Rank #1758XENE

Xenon Pharmaceuticals Inc.

$43.08

1.34% (Daily)

Market Cap

$3.33B

Revenue

$7.50M

Rank by MCap

#1758

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.

Headquarters

Burnaby, BC

Employees

316

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as majo...